New surgical trick may tame 'Rocky Hard' cataracts
NCT ID NCT07654387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two surgical techniques for removing very hard cataracts, which are tough to break apart and can lead to complications like corneal swelling or lens rupture. The new method, called 'divide and conquer with debulking,' aims to make the procedure safer. Researchers will measure eye cell health and other outcomes in 50 adults with hard cataracts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
phacoemulsification surgery with debulking technique
What this could lead to
If successful, this technique could reduce complications like corneal swelling and improve recovery for people with very hard cataracts.
What could go wrong
This is a small, early-stage study with only 50 participants. The new technique may not prove safer or more effective than the standard method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••